Page last updated: 2024-10-28

glyburide and Bright Disease

glyburide has been researched along with Bright Disease in 1 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reddi, AS1
Oppermann, W1
Patel, DG1
Ehrenreich, T1
Camerini-Davalos, RA1

Other Studies

1 other study available for glyburide and Bright Disease

ArticleYear
Diabetic microangiopathy in KK mice. III. Effect of prolonged glyburide treatment on glomerulosclerosis.
    Experimental and molecular pathology, 1978, Volume: 29, Issue:1

    Topics: Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Glomerulonephritis; Glomeruloscle

1978